Chris bell interviews Michael Arnold DNP, FHRS, about what is new in CCM therapy and when GDMT is not enough.

Join us for a conversation with a heart failure nurse leader who’s been at the forefront of remote monitoring. In this episode, we explore the clinical value of CardioMEMS in managing heart failure, especially for patients who appear stable but are at high risk for decompensation—along with insights on the expanded National Coverage Determination and the future of cardiovascular care.

A review of UltraFiltration as a therapeutic modality to overcome chronically decompensated heart failure in patients who struggle poorly responsive to diuretics. A brief review of pivotal trials as well as discussion of real-world experience with the therapy in a successful advanced heart failure clinic.

Abbott celebrated the 10 year anniversary of the FDA approval of CardioMEMS. On this podcast Chris Bell talks to Rebecca (Beki) Angerstein about the legacy of CardioMEMS. Beki is currently the Manager in Medical Affairs at Abbott. Her clinical background includes managing CV patients at the bedside and in a large cardiology practice for many years. She continues to practice clinically working prn in the hospital. Her passion is heart failure which led her to Abbott where she worked with clinicians on HF research trials.

**Please note that the website stated during the podcast was incorrect. For more information please visit www.cardiovascular.abbott**

In this episode of Heart Failure Focus, Chris Bell talks about structural heart disease, specifically mitraclip, and upcoming trials with Kristy Gam, NP, Lead APP for General Cardiology at the University of Colorado Hospital and Assistant Professor of Medicine in outpatient Interventional/Structural Cardiology.

In this episode of Heart Failure Focus, Chris Bell talks about what's new and hot in heart failure with Midge Bowers, a Clinical Professor and Lead Faculty for the cardiovascular specialty at Duke University School of Nursing. They review the “4 Pillar” therapy for HFrEF as well as discuss the emerging phenotypes of HFpEF.

Brief discussion with Dr. Phil Adamson, Divisional VP & CMO for the Heart Failure Division at Abbott , and longtime support of AAHFN.

Listen as he discusses the role of device therapy & remote monitoring in heart failure from a personal and corporate perspective.

This podcast discusses the importance of being accurate with NYHA Functional Classification as well as the current study that is focused on NYHA classification.